Close Menu
Home › hereditary cancer

hereditary cancer

Feb 06, 2020

Myriad Genetics Q2 Revenues Decrease 10 Percent; CEO Mark Capone Steps Down

The company attributed its revenue shortfall to billing issues in the prenatal testing business and announced that CFO Bryan Riggsbee will be interim CEO.

Feb 06, 2020

Despite Barriers, Labs Starting to Report Suspected Cancer Risk Mutations Seen in Tumor Testing

Premium

Paired tumor/germline analysis is not routinely done in cancer care, but some labs are starting to report incidental germline findings alongside patient's tumor profiles.

Nov 21, 2019

Myriad Genetics BRACAnalysis Approved by Japanese Regulators

Doctors can now order the test to identify breast cancer patients with BRCA1/2 mutations who may be eligible for surgery or targeted therapy.

Nov 06, 2019

Invitae Q3 Revenues Grow 51 Percent

The firm generated $56.5 million in revenue compared to $37.4 million in Q3 2018, and beat the consensus Wall Street estimate of $55.0 million

Nov 04, 2019

Myriad Genetics Fiscal Q1 Revenues Drop 8 Percent on Hereditary Cancer Testing Coding Challenges

The company had a challenging fiscal first quarter due to the deletion of CPT codes that payors used to use to reimburse hereditary cancer testing. 

Oct 29, 2019

CMS Proposes New National Coverage Policy for NGS Germline Testing

CMS has attempted to address stakeholders' concerns about its coverage criteria for germline NGS testing in a new proposed national policy.

Oct 18, 2019

Color, Ochsner Health System Collaborating on Population Health Pilot

Within the program, Ochsner is hoping to improve preventive care in certain cancer and cardiac conditions with information from genetic tests performed by Color.

Oct 04, 2019

Adding RNA-Seq, Ambry Genetics Expects to Reduce VUS Results in Hereditary Cancer Tests

Premium

The firm hopes to return fewer VUS in its test reports and to accelerate the resolution of uncertain results issued to patients in that past.

Sep 30, 2019

Lucence Diagnostics Singapore Lab Receives CLIA Certification

The lab can now receive US specimens for testing with its LiquidHallmark blood test that detects cancer-causing gene mutations and viruses.

Sep 05, 2019

Large-Scale Multigene Panel Study of Hereditary Cancer Risk Refines Gene Associations

Premium

The team analyzed multigene panel test data from Ambry Genetics for 165,000 individuals, focusing on hereditary cancer risk related to 32 genes in six cancer types.

Pages

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.